Login
$HYPR
$0.62 +$0.01 (2.02%) After hours

$HYPR 8-K SEC Filings

Filed On Filing
09 Nov 2026 8-K: Results of Operations and Financial Condition

GUILFORD, Conn.--(BUSINESS WIRE)--November 9, 2026--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the...

08 Oct 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Exhibit 99.2 AI-POWERED, PORTABLE BRAIN MRI ® The Swoop Portable MR Imaging System is Driving the Future of Brain Health Corporate Investor Deck – October 2026 The Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks ...

18 Sep 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

On September 17, 2026, Hyperfine, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the clos...

06 Aug 2026 8-K: Results of Operations and Financial Condition

GUILFORD, Connecticut, August 6, 2026 (GLOBE NEWSWIRE) – Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR)...

21 May 2026 8-K: Submission of Matters to a Vote of Security Holders

On May 21, 2026, Hyperfine, Inc. (the “Company”) held its 2026 annual meeting of stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on two proposals, each of which is described in more detail in ...

12 May 2026 8-K: Results of Operations and Financial Condition

GUILFORD, Connecticut, May 12, 2026 (GLOBE NEWSWIRE) – Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) b...

18 Mar 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

[***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

18 Mar 2026 8-K: Results of Operations and Financial Condition

GUILFORD, Connecticut, March 18, 2026 (GLOBE NEWSWIRE) – Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR)...

12 Jan 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Exhibit 99.2 AI-POWERED, PORTABLE BRAIN MRI The Swoop® Portable MR Imaging System is Driving the Future of Brain Health Corporate Investor Deck – January 2026 The Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks o...

29 Dec 2025 8-K: Entry into a Material Definitive Agreement; Other Events

Hyperfine, Inc., a Delaware corporation (the “Company”), and B. Riley Securities, Inc. (“B. Riley Securities”) are parties to that certain At Market Issuance Sales Agreement, dated November 9, 2023 (the “Original Agreement”). The Company...

13 Nov 2025 8-K: Results of Operations and Financial Condition

GUILFORD, Connecticut, November 13, 2025 (GLOBE NEWSWIRE) – Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (...

16 Oct 2025 8-K: Entry into a Material Definitive Agreement; Other Events

INTRODUCTORY. Hyperfine, Inc., a Delaware corporation (the “Company”), proposes to sell, pursuant to the terms of this Agreement, to the several underwriters named in Schedule A hereto (the “Underwriters,” or, each, an “Underwriter”), an...

15 Oct 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more

Exhibit 99.2 AI-POWERED, PORTABLE BRAIN MRI The Swoop® Portable MR Imaging System is Driving the Future of Brain Health Corporate Investor Deck – October 2025 The Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks o...

13 Aug 2025 8-K: Results of Operations and Financial Condition

GUILFORD, Connecticut, August 13, 2025 (GLOBE NEWSWIRE) – Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR...

06 Aug 2025 8-K: Other Events

As previously reported, on April 30, 2025, Hyperfine, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company th...

23 May 2025 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

19 May 2025 8-K: Submission of Matters to a Vote of Security Holders

On May 19, 2025, Hyperfine, Inc. (the “Company”) held its 2025 annual meeting of stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on two proposals, each of which is described in more detail in ...

13 May 2025 8-K: Results of Operations and Financial Condition

GUILFORD, Connecticut, May 13, 2025 (GLOBE NEWSWIRE) – Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) b...

02 May 2025 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

On April 30, 2025, Hyperfine, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing ...

17 Mar 2025 8-K: Results of Operations and Financial Condition

GUILFORD, Connecticut, March 17, 2025 (GLOBE NEWSWIRE) – Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR)...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support